TY - DATA T1 - Patient Disposition Flow Chart for Patients with HCV GT4. PY - 2017/01/05 AU - Tarik Asselah AU - Christophe Moreno AU - Christoph Sarrazin AU - Michael Gschwantler AU - Graham R. Foster AU - Antonio CraxĂ­ AU - Peter Buggisch AU - Faisal Sanai AU - Ceyhun Bicer AU - Oliver Lenz AU - Gino Van Dooren AU - Catherine Nalpas AU - Isabelle Lonjon-Domanec AU - Michael Schlag AU - Maria Buti UR - https://plos.figshare.com/articles/figure/Patient_Disposition_Flow_Chart_for_Patients_with_HCV_GT4_/4521257 DO - 10.1371/journal.pone.0168713.g001 L4 - https://ndownloader.figshare.com/files/7322108 KW - on-treatment virologic response KW - 12 weeks KW - virologic response 12 weeks post-treatment KW - HCV GT 4 infection KW - 12- week group KW - SVR 12. Methods KW - 48- week combination regimen KW - 24- week group KW - safety signals KW - simeprevir KW - METAVIR KW - On-Treatment Virologic Response Background HCV GT 4 accounts KW - Primary study objectives KW - Hepatitis C Virus KW - Primary efficacy outcome KW - favourable baseline characteristics KW - 67 patients KW - virologic response KW - 12- week treatment KW - CT KW - RNA KW - Week 24. Results KW - IL 28B CC patients KW - IU KW - HCV GT 4 KW - NCT KW - PR therapy N2 - Patient Disposition Flow Chart for Patients with HCV GT4. ER -